» Articles » PMID: 18028277

Potential and Limitation of UVC Irradiation for the Inactivation of Pathogens in Platelet Concentrates

Overview
Journal Transfusion
Specialty Hematology
Date 2007 Nov 22
PMID 18028277
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pathogen contamination, causing transfusion-transmitted diseases, is an ongoing concern in transfusion of cellular blood products. In this explorative study, the pathogen-inactivating capacity of UVC irradiation in platelet (PLT) concentrates was investigated. The dose dependencies of inactivation of several viruses and bacteria were compared with the effect on PLT quality.

Study Design And Methods: The potential of UVC irradiation was studied with a range of lipid-enveloped (LE) and non-lipid-enveloped viruses (NLE) and bacteria. LE viruses were bovine viral diarrhea virus (BVDV), human immunodeficiency virus (HIV), pseudorabies virus (PRV), transmissible gastroenteritis virus (TGEV), and vesicular stomatitis virus (VSV). NLE viruses were canine parvovirus (CPV) and simian virus 40 (SV40). Bacteria were Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Bacillus cereus. After spiking and irradiation, samples were tested for residual infectivity and reduction factors (RFs) were calculated. Furthermore, the effect of UVC irradiation on PLT quality was determined by measuring in vitro quality variables.

Results: A UVC dose of 500 J per m(2) resulted in acceptable PLT quality (as measured by pH, lactate production, CD62P expression, and exposure of phosphatidylserine) and high RFs (>4 log) for CPV, TGEV, VSV, S. epidermidis, S. aureus, and E. coli. Intermediate RFs (approx. 3 log) were observed for BVDV, PRV, and B. cereus. Low RFs (approx. 1 log) were found for HIV and SV40. No differences in virus reduction were observed between cell-free and cell-associated virus.

Conclusion: UVC irradiation is a promising pathogen-reducing technique in PLT concentrates, inactivating bacteria, and a broad range of viruses (with the exception of HIV) under conditions that have limited effects on PLT quality. Further optimization of the UVC procedure, however, is necessary to deal with blood-borne viruses like HIV.

Citing Articles

Systematic evaluating and modeling of SARS-CoV-2 UVC disinfection.

Freeman S, Kibler K, Lipsky Z, Jin S, German G, Ye K Sci Rep. 2022; 12(1):5869.

PMID: 35393480 PMC: 8988105. DOI: 10.1038/s41598-022-09930-2.


Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies.

Eddins D, Bassit L, Chandler J, Haddad N, Musall K, Yang J Immunohorizons. 2022; 6(2):144-155.

PMID: 35173021 PMC: 9164212. DOI: 10.4049/immunohorizons.2200005.


Inactivation of multidrug-resistant bacteria and bacterial spores and generation of high-potency bacterial vaccines using ultrashort pulsed lasers.

Tsen S, Popovich J, Hodges M, Haydel S, Tsen K, Sudlow G J Biophotonics. 2021; 15(2):e202100207.

PMID: 34802194 PMC: 8934174. DOI: 10.1002/jbio.202100207.


Mechanism of transient photothermal inactivation of bacteria using a wavelength-tunable nanosecond pulsed laser.

Tatsuno I, Niimi Y, Tomita M, Terashima H, Hasegawa T, Matsumoto T Sci Rep. 2021; 11(1):22310.

PMID: 34785646 PMC: 8595719. DOI: 10.1038/s41598-021-01543-5.


UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses.

Bhardwaj S, Singh H, Deep A, Khatri M, Bhaumik J, Kim K Sci Total Environ. 2021; 792:148548.

PMID: 34465056 PMC: 8238411. DOI: 10.1016/j.scitotenv.2021.148548.